Apigenin for Anxiety Relief

Research suggests that apigenin, a flavonoid compound found in chamomile and other plants, may contribute to anxiety relief primarily through its interactions with GABA receptors in the brain, the same inhibitory signaling system targeted by benzodiazepine medications. Studies indicate that this mechanism has been identified in flavonoid receptor research and is thought to underlie some of the calming effects observed in chamomile-based clinical trials, including those examining relief from anxiety-related symptoms in conditions like PMS and post-COVID neurological complaints. The available evidence comes largely from narrative and systematic reviews rather than clinical trials studying apigenin in isolation, which is an important limitation — most human research examines chamomile as a whole plant extract, making it difficult to attribute observed effects specifically to apigenin versus other active compounds present. Researchers have also noted that because people consume multiple flavonoids simultaneously, the combined effects on GABA receptors remain poorly understood, and further controlled trials isolating apigenin's role would be needed before stronger conclusions can be drawn.